SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (OnlineFirst PDF)
Right arrow All Versions of this Article:
0003319708319643v1
59/2_suppl/58S    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Filippatos, T. D.
Right arrow Articles by Mikhailidis, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Filippatos, T. D.
Right arrow Articles by Mikhailidis, D. P.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Statins and Heart Failure

Theodosios D. Filippatos, MD and Dimitri P. Mikhailidis, MD, FACB, ASA, FFPM, FRCP, FRCPath*

Royal Free Hospital

* To whom correspondence should be addressed. E-mail: Mikhailidis{at}aol.com.


  Abstract
Retrospective studies show that statin use prevents congestive heart failure and decreases mortality in patients with congestive heart failure; however, only one prospective study is available. In the Controlled Rosuvastatin Multinational Trial in Heart Failure study, rosuvastatin (10 mg/d) was compared with placebo in patients with advanced coronary heart disease–related congestive heart failure. There was no significant difference between rosuvastatin and placebo except for hospitalization rates. Statins must be given to all patients with coronary heart disease as early as possible because they may not work in patients with advanced congestive heart failure.

First published on May 28, 2008, doi:10.1177/0003319708319643

Angiology 2008;59:58S.

A more recent version of this article appeared on August 1, 2008

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 ANGIOLOGYHome page
K. I. Paraskevas, C. Psathas, T. Dragios, D. G. Chatzis, D. P. Mikhailidis, and Z. S. Kyriakides
The Impact of Novel Treatment Modalities on the Therapeutic Approach of Cardiovascular Diseases
Angiology, February 1, 2009; 60(1): 5 - 7.
[PDF]


Advertisement